Literature DB >> 8851758

Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography.

T Akashi1, T Nefuji, M Yoshida, J Hosoda.   

Abstract

The quantitative determination of FK506, an immunosuppressant for organ transplants, was studied by using reversed-phase high performance liquid chromatography. There were three peaks corresponding to FK506 and its tautomeric compounds on the chromatogram obtained from aqueous solution. Interconversion among these compounds due to epimerization occurs and then reaches an equilibrium in aqueous solution. An increase in the water content in water-solvent solutions caused by the peak areas of FK506 and Tautomer I to decrease and that of Tautomer II to increase. For quantitative analyses of aqueous solutions this creates a problem because the composition of the mixture at equilibrium varies with the water content. A simple method, using a solution of polyoxyethylene lauryl alcohol ether (Brij-35) as a diluent, has been developed to provide a constant equilibrium. By diluting the sample with the Brij-35 diluent, it is possible to quantify FK506 in aqueous solutions. The reliability of the proposed method was confirmed with samples extracted from fermentation broth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851758     DOI: 10.1016/0731-7085(95)01605-8

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Respirable low-density microparticles formed in situ from aerosolized brittle matrices.

Authors:  Alan B Watts; Yi-Bo Wang; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2012-11-15       Impact factor: 4.200

2.  Boosting the anti-inflammatory effect of self-assembled hybrid lecithin-chitosan nanoparticles via hybridization with gold nanoparticles for the treatment of psoriasis: elemental mapping and in vivo modeling.

Authors:  Salma Fereig; Ghada M El-Zaafarany; Mona Arafa; Mona M A Abdel-Mottaleb
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

3.  Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models.

Authors:  Leslie Rebibo; Connie Tam; Yan Sun; Eve Shoshani; Amit Badihi; Taher Nassar; Simon Benita
Journal:  J Control Release       Date:  2021-03-30       Impact factor: 9.776

4.  Development and Effects of FTY720 Ophthalmic Solution on Corneal Allograft Survival.

Authors:  Zhaochuan Liu; Haotian Lin; Chulong Huang; Wan Chen; Wu Xiang; Yu Geng; Weirong Chen
Journal:  Sci Rep       Date:  2015-11-12       Impact factor: 4.379

5.  Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement.

Authors:  Poovizhi Ponnammal; Parijat Kanaujia; Yin Yani; Wai Kiong Ng; Reginald B H Tan
Journal:  Pharmaceutics       Date:  2018-03-16       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.